Key result
This review addresses the diagnostic and therapeutic aspects of hibernating myocardium, including the potential role of neurohormonal antagonists.
This review summarizes the diagnostic and therapeutic aspects of hibernating myocardium, including the potential role of neurohormonal antagonists.
Answers are grounded in this paper and cite their sources.
Neurohormonal antagonists lack defined protocols in hibernating myocardium; leaves open prospective trials to clarify management of reversible LV dysfunction.
Hibernating myocardium is characterized by chronic reduction of myocardial blood flow due to obstructive coronary artery disease, causing reversible left ventricular dysfunction and flow-metabolism mismatch. The condition is unstable and increasing demand may lead to further left ventricular dysfunction or necrosis causing death or worsening heart failure. Recognition of the condition is difficult and requires complex cardiac imaging protocols. Treatment protocols are also poorly defined. This review addresses both the diagnostic and therapeutic aspects of hibernating myocardium.
No takes yet. Share an insight, caveat, or question.
Lahiri et al. (1999) conducted a review in Hibernating myocardium. Neurohormonal Antagonists was evaluated. This review addresses the diagnostic and therapeutic aspects of hibernating myocardium, including the potential role of neurohormonal antagonists.
Synapse has enriched 10 related papers. Consider them for comparative context: